Impact of grading of liver metastasis on postoperative outcome in patients with liver metastases from colorectal cancer

Hepato-Gastroenterology

Volumn 59, Issue 113, 2012, Pages 54-58

  Ishizuka, Mitsuru ^a   Kita, Junji ^a   Shimoda, Mitsugi ^a   Kato, Masato ^a   Sawada, Tokihiko ^a   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Albumin; CRP; Grading of liver metastasis; Nomogram

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURGERY; COLORECTAL CANCER; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NOMOGRAMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858268589     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11358     Document Type: Article

References (17)

1. Masi G, Allegrini G, Cupini S, Marcucci L, Cerri E, Brunetti I, et al.: First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOX-IRI): results of a phase II study with a simplified biweekly schedule. Ann Oncol 2004; 15:1766-1772. (Pubitemid 40012243)
2. Ruzzo A, Graziano F, Loupakis F, Rulli E, Canestrari E, Santini D, et al.: Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol 2007; 25:1247-1254. (Pubitemid 46640571)
3. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, et al.: Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994; 115:674-677. (Pubitemid 24189760)
4. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al.: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77:1254-1262. (Pubitemid 26102322)
5. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P: A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166:63-67. (Pubitemid 32565343)
6. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003; 21:3647-3650. (Pubitemid 46594058)
7. Kattan MW, Gonen M, Jarnagin WR, DeMatteo R, D'Angelica M, Weiser M, et al.: A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247:282-287. (Pubitemid 351156771)
8. Yamaguchi T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, Kato T: A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis. Hepatogastroenterology 2008; 55:173-178. (Pubitemid 351462185)
9. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al.: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243:1-7. (Pubitemid 43054046)
10. Wong VK, Malik HZ, Hamady ZZ, Al-Mukhtar A, Gomez D, Prasad KR, et al.: C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 2007; 96:222-225. (Pubitemid 46160625)
11. Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, Garden OJ, et al.: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995; 75:2077-2082.
12. McMillan DC, Canna K, McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003; 90:215-219. (Pubitemid 36237897)
13. Nozoe T, Matsumata T, Kitamura M, Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176:335-338. (Pubitemid 28514444)
14. Guillem P, Triboulet JP: Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 2005; 18:146-150. (Pubitemid 41801107)
15. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA, Fearon KC: Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 2006; 95:1568-1575. (Pubitemid 44863361)
16. Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, et al.: C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 2006; 12:5495-5500. (Pubitemid 44501808)
17. Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR, et al.: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 2003; 138:962-966. (Pubitemid 37099870)